JPMorgan Chase & Co. Has $12.60 Million Position in National Health Investors, Inc. (NYSE:NHI)

JPMorgan Chase & Co. trimmed its stake in National Health Investors, Inc. (NYSE:NHI - Free Report) by 5.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 149,896 shares of the real estate investment trust's stock after selling 8,717 shares during the quarter. JPMorgan Chase & Co. owned 0.33% of National Health Investors worth $12,600,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in the stock. Zimmer Partners LP bought a new position in National Health Investors during the third quarter valued at approximately $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in National Health Investors by 332.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust's stock valued at $20,370,000 after acquiring an additional 186,238 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in National Health Investors by 17.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust's stock valued at $71,651,000 after acquiring an additional 123,596 shares in the last quarter. Waterfront Capital Partners LLC bought a new position in National Health Investors during the third quarter valued at approximately $10,097,000. Finally, Easterly Investment Partners LLC bought a new position in shares of National Health Investors in the third quarter valued at approximately $5,632,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Stock Performance

Shares of National Health Investors stock traded down $1.49 during midday trading on Friday, hitting $66.22. The company had a trading volume of 231,696 shares, compared to its average volume of 254,599. The business's 50 day simple moving average is $73.62 and its two-hundred day simple moving average is $75.88. The stock has a market cap of $3.01 billion, a PE ratio of 22.76, a P/E/G ratio of 4.86 and a beta of 1.06. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. National Health Investors, Inc. has a 1-year low of $51.59 and a 1-year high of $86.13.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The company's revenue was up 1.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.08 EPS. As a group, equities analysts predict that National Health Investors, Inc. will post 4.42 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.90 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a yield of 5.44%. National Health Investors's dividend payout ratio is currently 123.71%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on NHI shares. Bank of America started coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They issued a "buy" rating and a $92.00 price target on the stock. StockNews.com lowered shares of National Health Investors from a "buy" rating to a "hold" rating in a research report on Tuesday, October 15th. Truist Financial dropped their price target on shares of National Health Investors from $78.00 to $72.00 and set a "hold" rating on the stock in a research report on Monday, December 23rd. Finally, Wells Fargo & Company lowered shares of National Health Investors from an "overweight" rating to an "equal weight" rating and lifted their price target for the company from $81.00 to $86.00 in a research report on Tuesday, October 1st. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $75.33.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.